Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR assay with competitive internal control for the detection of hepatitis C virus RNA
- PMID: 16201892
- DOI: 10.1515/CCLM.2005.139
Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR assay with competitive internal control for the detection of hepatitis C virus RNA
Abstract
Nucleic acid amplification testing for hepatitis C virus (HCV) RNA has become an essential tool for the prevention and clinical management of hepatitis C. We describe the development, validation and evaluation of a homogenous reverse transcriptase-initiated HCV-PCR assay with competitive internal control that is applicable to both the quantitative detection of HCV genomes in single patient samples and the screening of blood donations by mini-pool testing. For the implementation of a positive run control, a HCV RNA-positive plasma sample was calibrated against an international HCV RNA standard preparation. For quantification purposes, an in vitro-transcribed RNA calibrator sequence was used. The detection limit of the assay (95% positive cut-off) was determined by probit analysis and was calculated as 114 IU/mL. Comparable sensitivity to different HCV template sequences was verified for HCV genotypes 1-5. Quantitative test results correlated well with viral loads that had been previously determined by the Bayer VERSANT HCV RNA 3.0 bDNA assay (n=53, R=0.943, p<0.001). During more than 5 years of blood donation testing, the specificity of the assay was found to be 99.51%. All assay components showed constant performance during this time period. In conclusion, we introduce a well-proven method that allows fast and reliable quantification of HCV genomes.
Similar articles
-
TaqMan amplification system with an internal positive control for HCV RNA quantitation.J Clin Virol. 2004 Nov;31(3):227-34. doi: 10.1016/j.jcv.2004.03.009. J Clin Virol. 2004. PMID: 15465417
-
Clinical performance of the LCx HCV RNA quantitative assay.J Virol Methods. 2005 Feb;123(2):171-8. doi: 10.1016/j.jviromet.2004.09.020. J Virol Methods. 2005. PMID: 15620399
-
Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.J Clin Microbiol. 2006 Mar;44(3):729-37. doi: 10.1128/JCM.44.3.729-737.2006. J Clin Microbiol. 2006. PMID: 16517847 Free PMC article. Clinical Trial.
-
Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products.J Clin Virol. 2001 Jan;20(1-2):7-13. doi: 10.1016/s1386-6532(00)00149-9. J Clin Virol. 2001. PMID: 11163577 Review.
-
Implementation of genome amplification technology for HCV RNA detection.Transfus Med. 2002 Aug;12(4):265-73. doi: 10.1046/j.1365-3148.2002.00388.x. Transfus Med. 2002. PMID: 12220256 Review. No abstract available.
Cited by
-
Strategic approach to produce low-cost, efficient, and stable competitive internal controls for detection of RNA viruses by use of reverse transcription-PCR.J Clin Microbiol. 2007 Nov;45(11):3555-63. doi: 10.1128/JCM.02601-06. Epub 2007 Aug 15. J Clin Microbiol. 2007. PMID: 17699653 Free PMC article.
-
Competitive RT-PCR Strategy for Quantitative Evaluation of the Expression of Tilapia (Oreochromis niloticus) Growth Hormone Receptor Type I.Biol Proced Online. 2009 Mar 10;11:79-98. doi: 10.1007/s12575-009-9002-3. Biol Proced Online. 2009. PMID: 19495916 Free PMC article.
-
Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion.PLoS One. 2015 Dec 14;10(12):e0145012. doi: 10.1371/journal.pone.0145012. eCollection 2015. PLoS One. 2015. PMID: 26658824 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources